Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jan 28:10:635555.
doi: 10.3389/fonc.2020.635555. eCollection 2020.

Editorial: Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology

Affiliations
Editorial

Editorial: Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology

Anton Buzdin et al. Front Oncol. .
No abstract available

Keywords: RNA sequencing; bioinformatics; biomarkers; cancer diagnostics; genomics; next generation sequencing; theranostics; transcriptomics.

PubMed Disclaimer

Conflict of interest statement

Author AB was employed by the company OmicsWay Corp. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology

References

    1. Buzdin A, Sorokin M, Garazha A, Glusker A, Aleshin A, Poddubskaya E, et al. RNA sequencing for research and diagnostics in clinical oncology. Semin Cancer Biol (2020) 60:311–23. 10.1016/j.semcancer.2019.07.010 - DOI - PubMed
    1. Buzdin A, Sorokin M, Garazha A, Sekacheva M, Kim E, Zhukov N, et al. Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs. Semin Cancer Biol (2018) 53:110–24. 10.1016/j.semcancer.2018.06.003 - DOI - PubMed
    1. Rodon J, Soria JC, Berger R, Miller WH, Rubin E, Kugel A, et al. Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. Nat Med (2019) 25:751–8. 10.1038/s41591-019-0424-4 - DOI - PMC - PubMed
    1. Negro G, Aschenbrenner B, Brezar SK, Cemazar M, Coer A, Gasljevic G, et al. Molecular heterogeneity in breast carcinoma cells with increased invasive capacities. Radiol Oncol (2020) 54:103–18. 10.2478/raon-2020-0007 - DOI - PMC - PubMed
    1. Skvortsova I. Special Issue “Enigmatic tumor properties associated with metastatic spread” seminars in cancer biology, volume XX. Semin Cancer Biol (2020) 60:iii–iv. 10.1016/j.semcancer.2019.10.021 - DOI - PubMed

Publication types

LinkOut - more resources